
31/03/2025
ATXA Therapeutics CEO & Founder Therese Kinsella was recently featured in the Business Post discussing the company's current fundraising and the plans to bring NTP42 through clinical trials in patients. Read more here...
ATXA, which is currently in the process of raising the β¬30 million, has been supported by Enterprise Ireland